Impero (IMPERO) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
12 Oct, 20262024 product releases
Reviewer tasks extend control activities to reviewers and second reviewers, supporting clearer review procedures and stronger control-review quality.
Task-based reports consolidate responsible and reviewer steps, control answers and actions; support comparisons across years, entities and regions.
Flexible reminders allow unlimited scheduled reminders before and after due dates, with mass updates across existing controls.
Customizable control exports let users select columns and apply filters, reducing irrelevant data and manual report cleanup.
November reporting release
One-click status reports for programs or individual controls automatically apply relevant program and activity filters, with performance statistics such as on-time rate and overdue controls.
Reports support analysis by control or country, drill-down to overdue activities, and actions such as sending reminders or reassigning work.
A redesigned report module adds report-type selection, searchable saved reports, and visibility into report access rights.
Ad hoc push reports send recipients key statistics and a link to the full report; send history and shared content are recorded in the platform.
Control testing launch
Control testing was planned as an add-on for mid-January 2025, with beta access available by contacting an account manager.
The module is designed to streamline planning through reporting, with customizable templates and access controls, sample selection, assigned tasks, evidence gathering and multi-entity testing.
The walkthrough covered selecting controls, defining test criteria and timelines, applying risk-based sampling, reviewing samples and submitting conclusions; reporting capabilities were planned for later development.
Latest events from Impero
- Q2 brought a new administrator dashboard; control testing was targeted for end-July launch as an add-on.IMPERO
Investor update - 2025 brought faster releases and new control tools; entity-level governance and opt-in AI are next.IMPERO
Investor update - Control Health reveals activity friction as workflow, analytics and AI capabilities expand.IMPERO
Investor update - ARR up 24% to DKK 50.6M, EBITDA positive, and DACH region ARR grew 35% year-over-year.IMPERO
Q2 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 2025 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 2024 - 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 2024 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 2024 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 2025